Data quality bias: an underrecognized source of misclassification in pay-for-performance reporting?

Quality Management in Health Care
Darcey D Terris, David G Litaker

Abstract

Pay-for-performance (P4P) initiatives, in which provider reimbursement is linked to quality assessment, are receiving increasing attention as a possible approach to encouraging and accelerating quality improvement in America's health care systems. The potential of P4P programs, however, is constrained by the quality of data and information resources available for performance reporting. Accurate and reliable appraisal of health care quality is a challenging issue, as achieving recommended processes of care and desired health outcomes is influenced by a diverse range of interrelated factors occurring at multiple levels and arising from multiple sources within the patient encounter, health care system, and larger environment. The challenge of quality assessment is further complicated by the variable quality of data available for reporting by each provider. When data quality varies systematically among providers, a significant risk of inequity in assessment, and therefore reimbursement under P4P programs, may occur. The issue of data quality should be investigated and addressed before widespread implementation of P4P programs is pursued. Significant investment in data collection and reporting mechanisms may be required, especially ...Continue Reading

References

Aug 6, 1998·Health Affairs·D M Eddy
Jun 15, 1999·JAMA : the Journal of the American Medical Association·A B Bindman
Jan 16, 2002·The Annals of Thoracic Surgery·D M ShahianP I Dreyer
Dec 3, 2003·Health Affairs·Donald M BerwickGail R Wilensky
Jan 23, 2004·The New England Journal of Medicine·Arnold M EpsteinMary Beth Hamel
Sep 16, 2005·Health Affairs·Catharine W Burt, Jane E Sisk
Aug 16, 2006·Annals of Internal Medicine·Laura A PetersenSupicha Sookanan
Sep 20, 2006·Environmental Health : a Global Access Science Source·Russell P Lopez, H Patricia Hynes
Oct 21, 2006·BMC Public Health·Carol R Williams Oladele, Elizabeth Barnett
Jun 19, 2007·Journal of Clinical Epidemiology·Darcey D TerrisSiran M Koroukian
Jan 22, 2008·Quality Management in Health Care·Brook WattsDuncan Neuhauser
Dec 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Constance LiuDavid Litaker

❮ Previous
Next ❯

Citations

Mar 5, 2010·The New England Journal of Medicine·Matthew K WyniaRomana Hasnain-Wynia
Feb 17, 2009·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Dale M NeedhamPeter J Pronovost
Feb 16, 2010·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Andreea Voinea-GriffinUNKNOWN DPBRN Collaborative Group
Jan 5, 2011·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Maggie JonesDavid Labby
Apr 29, 2010·BMC Oral Health·Andreea Voinea-GriffinMonika M Safford
Aug 25, 2010·BMC Health Services Research·Pieter Van HerckWalter Sermeus
Jan 22, 2008·Quality Management in Health Care·Marissa A Hendrickson
Oct 18, 2008·Journal of the American College of Surgeons·Hiram C Polk, Steven Vallance
Apr 6, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Kathryn E Arnold, Nicola D Thompson
Jun 9, 2012·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Nicola D ThompsonScott K Fridkin
Jan 16, 2020·BMC Medical Research Methodology·Thomas WoodcockMary Dixon-Woods
Aug 26, 2019·BMJ Quality & Safety·Thomas WoodcockMary Dixon-Woods

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.